APA引文

Mezö, B., Horváth, O., Sinkovits, G., Veszeli, N., Kriván, G., & Prohászka, Z. (2020). Validation of Early Increase in Complement Activation Marker sC5b-9 as a Predictive Biomarker for the Development of Thrombotic Microangiopathy After Stem Cell Transplantation. Front Med (Lausanne).

Citação norma Chicago

Mezö, Blanka, Orsolya Horváth, György Sinkovits, Nóra Veszeli, Gergely Kriván, and Zoltán Prohászka. "Validation of Early Increase in Complement Activation Marker SC5b-9 As a Predictive Biomarker for the Development of Thrombotic Microangiopathy After Stem Cell Transplantation." Front Med (Lausanne) 2020.

MLA引文

Mezö, Blanka, et al. "Validation of Early Increase in Complement Activation Marker SC5b-9 As a Predictive Biomarker for the Development of Thrombotic Microangiopathy After Stem Cell Transplantation." Front Med (Lausanne) 2020.